EPISODE · Jun 4, 2025 · 8 MIN
Alcon Gains FDA Approval for Novel DED Drug
from Eyewire News: The Podcast · host Eyewire News
Alcon receives FDA approval for a novel pharmaceutical treatment for dry eye disease; Genentech’s Susvimo ocular implant is approval for a third indication in the US; and the makers of two investigational treatments for wet AMD complete enrollment in their respective phase 3 trials. Learn more about your ad choices. Visit megaphone.fm/adchoices
NOW PLAYING
Alcon Gains FDA Approval for Novel DED Drug
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m